Our website uses cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google AdSense, Google Analytics, YouTube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

MoHP Regulates Use of Medical Implants and Stents to Ensure Fair Access and Affordability

Government Mandates Transparency and Affordability in Life-Saving Medical Devices Across All Public Hospitals
Use of Medical implants and stents to be regulated in public hospitals

Background

In a significant move to promote health equity and patient safety, the Ministry of Health and Population (MoHP), Nepal, issued an official directive (dated 02/02/ 2082 B.S.) regulating the use of Medical Implants and Stents in all public hospitals and government health institutions across the country.

The directive aims to eliminate unnecessary costs, ensure product transparency, and promote affordable access to life-saving devices like cardiac stents and orthopedic implants — crucial tools in modern clinical treatment.

Key Provisions of the Notice

The circular outlines three major regulatory actions:

1. Pre-Approval and Public Disclosure

  • All public hospitals must obtain pre-approval for every brand and type of Medical Implant/Stent to be used.
  • Names, manufacturing companies, product types, and MRPs (Maximum Retail Prices) must be disclosed at least 15 days in advance and published on hospital websites.
  • Only those publicly declared and approved devices will be allowed for use in hospitals.

2. New Product Introduction

  • For newly introduced Medical Implants/Stents, the hospital must disclose:
    • Manufacturer’s name
    • Quality details
    • Nepalese distributor
    • Final market price
  • These must be made public before use, ensuring complete transparency and procurement accountability.

3. Fair Pricing and Grievance Handling

  • Hospitals must ensure that all implants/stents are available at fair and accessible prices to all patients.
  • Mechanisms to handle patient grievances and prevent price exploitation must be put in place.
  • The government will monitor hospitals for compliance to this directive.

Why It Matters

This directive is a landmark step in:

  • Preventing price manipulation by private suppliers and intermediaries.
  • Protecting vulnerable patients from exploitative billing for life-saving devices.
  • Enhancing public trust in the healthcare system.
  • Aligning with Universal Health Coverage (UHC) goals and WHO resolutions on price transparency.

🌐 For More Information:

Official Website: www.mohp.gov.np

📌 Summary Infographic:

Regulation AreaRequirement
Product UseOnly pre-approved and disclosed medical implants/stents
Disclosure TimelineAt least 15 days before hospital use
Required InfoName, type, manufacturer, distributor, price
For New ProductsMust be disclosed prior to use with full specifications
Pricing PolicyFair pricing for all; hospitals accountable for transparent billing practices
Monitoring & GrievanceHospitals to ensure no exploitation; patients can file complaints

Discover more from Public Health Concern Nepal

Subscribe to get the latest posts sent to your email.

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This

Discover more from Public Health Concern Nepal

Subscribe now to keep reading and get access to the full archive.

Continue reading